Forman Stephen J.
SEC insider (Form 3/4/5 filer). CIK 0001676461. Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2025. Located in PASADENA, CA.
Companies Forman Stephen J. has filed insider reports for
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT): Director
Forman Stephen J.
CIK: 0001676461
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 30, 2025LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
10K shares- - Jun 30, 2025LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
7.8K shares- - Mar 31, 2025LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
5.9K shares- - Jan 20, 2025LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
3K shares- - Sep 30, 2024LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
3.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2025 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 10,000 | - | - | Direct |
| Jun 30, 2025 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 7,754 | - | - | Direct |
| Mar 31, 2025 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 5,851 | - | - | Direct |
| Jan 20, 2025 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 3,030 | - | - | Direct |
| Sep 30, 2024 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 3,858 | - | - | Direct |
1-5 of 5 transactions